Search Results For ''

  • We wade through this radiopharmaceutical company’s news so you don’t have to

    Seeing ‘Cu-64 SAR-bisPSMA’ in the title of an ASX announcement is enough to make many keep scrolling. However, clued in investors who read on and plug ‘radiopharmaceuticals’ into their search bar will uncover the massive market value of the space and its transformative potential. Clinical stage radiopharmaceutical company Clarity Pharmaceuticals (ASX: CU6) is an oncologyRead More
    Public
  • PainChek expands across New Zealand with pain tech deployed to 24 aged care facilities

    Confident in their technology that can accurately assess a patient’s pain simply from a short video of their face, medtech company PainChek (ASX: PCK) has successfully converted a 6-month trial with one of New Zealand’s largest aged care operators into a full revenue-generating contract. The contract comes after Summerset Holdings (ASX: SNZ) trialled PainChek’s smartphone

    Read More
    Public
  • German Ice Hockey Federation to trial HITIQ’s concussion tech mouthguards

    With the AFL season having just kicked off, it didn’t take long for attention to be drawn to the league’s concussion protocols but having already partnered with the AFL, concussion tech company HITIQ (ASX: HIQ) has continued its international expansion having been engaged by the German Ice Hockey Federation. The long-term impact of concussion continues

    Read More
    Public
  • Conversational AI & the Metaverse: The Future of Digital Interaction

    The age of the metaverse is upon us; touted by Big Tech experts as the coming of the next internet and predicted to deliver a transcendent, immersive and 3D cyber experience. It presents an opportunity to redefine interactions by removing limitations and allowing conversations to take place through the humanisation of artificial objects. In this

    Read More
    Public
  • Predictive test for diabetic kidney disease receives new patent

    12% of global health expenditure is spent on diabetes. That equates to approximately USD $673 billion. Scarily, 1 in 2 adults with diabetes is undiagnosed.  Diabetic kidney disease (DKD) is directly caused by diabetes, and the damage the disease does to the kidneys. It is estimated that 1 in 3 diabetics will go on to

    Read More
    Public
  • Cettire founder cashes out $47m as boom stock comes back down to earth

    If shareholder confidence is a sign of things to come, rocky waters may be ahead for luxury goods retailer Cettire (ASX: CTT) after its Founder and CEO cashed out $47.25 million of his shares with a pretty good idea of how their financial results for the year are going to look.  Keen investors have been

    Read More
    Public